Literature DB >> 15663355

Mechanisms of transformation by MLL.

Jay L Hess1.   

Abstract

Rearrangements of the mixed-lineage leukemia gene MLL1 (MLL, HRX, ALL1), the human homologue of the Drosophila gene trithorax, are associated with aggressive acute leukemias in both children and adults. Transformation by rearranged forms of MLL1, including in-frame fusion proteins, partial tandem duplications, and amplification of MLL1 through upregulation of Hox gene and cofactor expression apparently results in a block in hematopoietic differentiation. MLL1 regulates Hox gene expression via direct promoter binding and histone H3 Lys 4 methylation mediated by the intrinsic methyltransferase activity of the SET domain. Mll1 knockout leads to loss of Hox gene expression, defects in hematopoiesis, and embryonic lethality. A close homologue, MLL2 is amplified in some solid tumors. MLL2 also has histone H3 Lys 4 methyltransferase activity that is dependent on menin, a protein mutated in multiple neoplasia type I (MEN1) and which is required for normal Hox expression. These findings underscore the importance of the MLL histone methyltransferases in development and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663355     DOI: 10.1615/critreveukaryotgeneexpr.v14.i4.10

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  29 in total

1.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

2.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

3.  Structural basis of the recognition of a methylated histone tail by JMJD2A.

Authors:  Zhongzhou Chen; Jianye Zang; John Kappler; Xia Hong; Frances Crawford; Qin Wang; Fei Lan; Chengyu Jiang; Johnathan Whetstine; Shaodong Dai; Kirk Hansen; Yang Shi; Gongyi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-13       Impact factor: 11.205

4.  Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.

Authors:  Thomas A Milne; Jaehoon Kim; Gang G Wang; Sonja C Stadler; Venkatesha Basrur; Sarah J Whitcomb; Zhanxin Wang; Alexander J Ruthenburg; Kojo S J Elenitoba-Johnson; Robert G Roeder; C David Allis
Journal:  Mol Cell       Date:  2010-06-10       Impact factor: 17.970

5.  Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.

Authors:  H Karimi Kinyamu; Jennifer B Collins; Sherry F Grissom; Pratibha B Hebbar; Trevor K Archer
Journal:  Mol Carcinog       Date:  2008-11       Impact factor: 4.784

6.  Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy.

Authors:  Shyh-Jen Shih; Joseph Fass; Vincent Buffalo; Dawei Lin; Sheetal P Singh; Manuel O Diaz; Andrew T Vaughan
Journal:  Br J Haematol       Date:  2012-07-30       Impact factor: 6.998

7.  Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.

Authors:  Jiangang Zhou; Xi Feng; Bin Ban; Jingxia Liu; Zhou Wang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

Review 8.  Chromatin tethering and retroviral integration: recent discoveries and parallels with DNA viruses.

Authors:  Anne M Meehan; Eric M Poeschla
Journal:  Biochim Biophys Acta       Date:  2009-10-15

9.  Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation.

Authors:  Yongguang Tao; Sichuan Xi; Victorino Briones; Kathrin Muegge
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

10.  Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.

Authors:  Anna M Eiring; Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Ji Suk Chang; Mario Notari; William Willis; Carlo Gambacorti-Passerini; Stefano Volinia; Guido Marcucci; Michael A Caligiuri; Gustavo W Leone; Danilo Perrotti
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.